EIF2AK3 and supranuclear palsy, progressive, 1: In summary, our data provide a novel functional model (Fig 6) to explain the association of PERK with the tauopathy PSP (Höglinger et al, 2011) and suggest that PERK activation may be a viable strategy to treat PSP and eventually other tauopathies.